These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16599848)

  • 1. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases.
    Jung K
    Clin Chem Lab Med; 2006; 44(4):500-2. PubMed ID: 16599848
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens.
    Thrailkill K; Cockrell G; Simpson P; Moreau C; Fowlkes J; Bunn RC
    Clin Chem Lab Med; 2006; 44(4):503-4. PubMed ID: 16599849
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9.
    Jung K; Klotzek S; Stephan C; Mannello F; Lein M
    Clin Chem; 2008 Apr; 54(4):772-3. PubMed ID: 18375496
    [No Abstract]   [Full Text] [Related]  

  • 4. Preanalytical biases in measurement of matrix metalloproteinases and their tissue inhibitors in peripheral blood.
    Jung K
    J Rheumatol; 2007 Apr; 34(4):890-2; author reply 892. PubMed ID: 17407248
    [No Abstract]   [Full Text] [Related]  

  • 5. Consideration of preanalytical impact of blood sampling on measurement of matrix metalloproteinases and their inhibitors as precondition to evaluate their relationship to clinical data.
    Jung K
    Mult Scler; 2009 Nov; 15(11):1372-3; author reply 1374-5. PubMed ID: 19965559
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of blood collection methods on gelatin zymography of matrix metalloproteinases.
    Mannello F
    Clin Chem; 2003 Feb; 49(2):339-40. PubMed ID: 12560371
    [No Abstract]   [Full Text] [Related]  

  • 7. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
    Fainardi E; Castellazzi M; Bellini T; Dallocchio F
    Mult Scler; 2007 May; 13(4):561-2. PubMed ID: 17463079
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrix metalloproteinases do not properly work as peripheral blood biomarkers without taking into account the preanalytical impact of blood sampling.
    Jung K
    Eur J Cardiothorac Surg; 2008 May; 33(5):944; author reply 945. PubMed ID: 18343680
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation.
    Mannello F
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):611-4. PubMed ID: 18354094
    [No Abstract]   [Full Text] [Related]  

  • 10. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
    Fainardi E; Castellazzi M; Bellini T; Dallocchio F
    Mult Scler; 2007 Jun; 13(5):691-2. PubMed ID: 17615626
    [No Abstract]   [Full Text] [Related]  

  • 11. Preanalytical pitfalls of blood sampling to measure true circulating matrix metalloproteinase 9 and tissue inhibitors of matrix metalloproteinases.
    Jung K; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2006 Nov; 373(1-2):180-1; author reply 182. PubMed ID: 16616058
    [No Abstract]   [Full Text] [Related]  

  • 12. Consideration of important preanalytical conditions for the assessment of circulating matrix metalloproteinase-9.
    John M; Jung K
    Am J Respir Crit Care Med; 2005 Jul; 172(2):254; author reply 254. PubMed ID: 16002574
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of matrix metalloproteinases and their tissue inhibitors in serum produces doubtful results.
    Jung K
    J Infect Dis; 2008 Dec; 198(11):1722-3; author reply 1723-4. PubMed ID: 19000015
    [No Abstract]   [Full Text] [Related]  

  • 14. Careful attention to blood sampling as a preanalytical determinant of circulating matrix metalloproteinase 9 to avoid misinterpretations: comment on the article by Ainiala et al.
    Jung K
    Arthritis Rheum; 2005 Feb; 52(2):673-4; author reply 674. PubMed ID: 15692966
    [No Abstract]   [Full Text] [Related]  

  • 15. Validating sampling methods for measurement of circulating matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1.
    Zhang RY; Cui W; Zhao KJ; Tang YQ; Li L
    Pancreas; 2010 Aug; 39(6):937; author reply 937-8. PubMed ID: 20664481
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating gelatinase B (MMP-9)--the impact of the preanalytical step of blood collection.
    Jung K; Lein M; Roemer A; Lichtinghagen R
    Matrix Biol; 2002 Aug; 21(5):381-2. PubMed ID: 12225801
    [No Abstract]   [Full Text] [Related]  

  • 17. Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood.
    Alby C; Ben Abdesselam O; Foglietti MJ; Beaudeux JL
    Clin Chim Acta; 2002 Nov; 325(1-2):183-6. PubMed ID: 12367785
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes.
    Jung K; Meisser A; Bischof P
    Int J Cancer; 2005 Oct; 116(6):1000-1; author reply 1002-3. PubMed ID: 15856460
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.